Promising Chinese Stocks To Keep An Eye On - October 9th

Key Points

• Five stocks highlighted: MarketBeat’s screener identified Diageo (DEO), China SXT Pharmaceuticals (SXTC), UP Fintech (TIGR), Baiya International Group (BIYA), and RBB Bancorp (RBB) as Chinese stocks with particularly high recent dollar trading volume.
• The companies span alcoholic beverages, traditional Chinese medicine, online brokerage, technology, and banking services, offering varied exposure to China-related economic activity.
• Investors should consider significant risks, including Chinese regulation and economic policy, geopolitical tensions, currency fluctuations, accounting differences, and— for Baiya—its offshore holding-company and variable-interest-entity structure.

Diageo, China SXT Pharmaceuticals, UP Fintech, Baiya International Group, and RBB Bancorp are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are shares of companies based in China or substantially connected to the Chinese economy, traded on exchanges such as those in Shanghai, Shenzhen, Hong Kong, or overseas markets. For investors, they may offer exposure to China’s growth but also carry risks related to government regulation, economic policy, geopolitical tensions, currency movements, and differences in accounting or market rules. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read Our Latest Research Report on SXTC

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Baiya International Group (BIYA)

We, Baiya International Group Inc. (“Baiya”), are an offshore holding company incorporated in the Cayman Islands. We are not a Chinese operating company, but an offshore holding company incorporated in the Cayman Islands. As a holding company, we have no material operations and conduct all of our operations in China through the VIE, Shenzhen Gongwuyuan Network Technology Co., Ltd.

Read Our Latest Research Report on BIYA

RBB Bancorp (RBB)

RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.

Read Our Latest Research Report on RBB

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.